Cargando…
Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment
OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286489/ https://www.ncbi.nlm.nih.gov/pubmed/35845091 http://dx.doi.org/10.2147/JIR.S351913 |
_version_ | 1784748023429988352 |
---|---|
author | Ullah, Aman Al Kury, Lina Tariq Althobaiti, Yusuf S Ali, Tahir Shah, Fawad ALi |
author_facet | Ullah, Aman Al Kury, Lina Tariq Althobaiti, Yusuf S Ali, Tahir Shah, Fawad ALi |
author_sort | Ullah, Aman |
collection | PubMed |
description | OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and oxidative stress. Targeting neuroinflammation and oxidative stress may be a useful strategy for preventing ethanol-induced neurodegeneration. METHODOLOGY: Firstly, the newly synthesized compounds were subjected to molecular simulation and docking in order to predict ligand binding status. Later, for in vivo observations, adult male Sprague Dawley rats were used for studying behavioral and oxidative stress markers. ELIZA kits were used to analyse tumour necrosis factor-alpha (TNF-), nuclear factor-B (NF-B), interleukin (IL-18), and pyrin domain-containing protein 3 (NLRP3) expression, while Western blotting was used to measure IL-1 and Caspase-1 expression. RESULTS: Our findings suggested that altered levels of antioxidant enzymes were associated with elevated levels of TNF-α, NF-B, IL-1, IL-18, Caspase-1, and NLRP3 in the ethanol-treated group. Furthermore, ethanol also caused memory impairment in rats, as measured by behavioural tests. Pretreatment using selected benzimidazole significantly increased the combat of the brain against ethanol-induced oxidative stress. The neuroprotective effects of benzimidazole derivatives were promoted by their free radical scavenging activity, augmentation of endogenous antioxidant proteins (GST, GSH), and amelioration of lipid peroxide (LPO) and other pro-inflammatory mediators. Molecular docking and molecular simulation studies further supported our hypothesis that the synthetic compounds Ca and Cb had an excellent binding affinity with proper bond formation with their targets (TNF-α and NLRP3). CONCLUSION: It is revealed that these benzimidazole derivatives can reduce ethanol-induced neuronal toxicity by regulating the expression of cytokines, antioxidant enzymes, and the inflammatory cascade. |
format | Online Article Text |
id | pubmed-9286489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-92864892022-07-16 Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment Ullah, Aman Al Kury, Lina Tariq Althobaiti, Yusuf S Ali, Tahir Shah, Fawad ALi J Inflamm Res Original Research OBJECTIVE: The study investigated the effect of newly synthesized benzimidazole derivatives against ethanol-induced neurodegeneration. According to evidence, ethanol consumption may cause a severe insult to the central nervous system (CNS), resulting in mental retardation, neuronal degeneration, and oxidative stress. Targeting neuroinflammation and oxidative stress may be a useful strategy for preventing ethanol-induced neurodegeneration. METHODOLOGY: Firstly, the newly synthesized compounds were subjected to molecular simulation and docking in order to predict ligand binding status. Later, for in vivo observations, adult male Sprague Dawley rats were used for studying behavioral and oxidative stress markers. ELIZA kits were used to analyse tumour necrosis factor-alpha (TNF-), nuclear factor-B (NF-B), interleukin (IL-18), and pyrin domain-containing protein 3 (NLRP3) expression, while Western blotting was used to measure IL-1 and Caspase-1 expression. RESULTS: Our findings suggested that altered levels of antioxidant enzymes were associated with elevated levels of TNF-α, NF-B, IL-1, IL-18, Caspase-1, and NLRP3 in the ethanol-treated group. Furthermore, ethanol also caused memory impairment in rats, as measured by behavioural tests. Pretreatment using selected benzimidazole significantly increased the combat of the brain against ethanol-induced oxidative stress. The neuroprotective effects of benzimidazole derivatives were promoted by their free radical scavenging activity, augmentation of endogenous antioxidant proteins (GST, GSH), and amelioration of lipid peroxide (LPO) and other pro-inflammatory mediators. Molecular docking and molecular simulation studies further supported our hypothesis that the synthetic compounds Ca and Cb had an excellent binding affinity with proper bond formation with their targets (TNF-α and NLRP3). CONCLUSION: It is revealed that these benzimidazole derivatives can reduce ethanol-induced neuronal toxicity by regulating the expression of cytokines, antioxidant enzymes, and the inflammatory cascade. Dove 2022-07-11 /pmc/articles/PMC9286489/ /pubmed/35845091 http://dx.doi.org/10.2147/JIR.S351913 Text en © 2022 Ullah et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Ullah, Aman Al Kury, Lina Tariq Althobaiti, Yusuf S Ali, Tahir Shah, Fawad ALi Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title | Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title_full | Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title_fullStr | Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title_full_unstemmed | Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title_short | Benzimidazole Derivatives as New Potential NLRP3 Inflammasome Inhibitors That Provide Neuroprotection in a Rodent Model of Neurodegeneration and Memory Impairment |
title_sort | benzimidazole derivatives as new potential nlrp3 inflammasome inhibitors that provide neuroprotection in a rodent model of neurodegeneration and memory impairment |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286489/ https://www.ncbi.nlm.nih.gov/pubmed/35845091 http://dx.doi.org/10.2147/JIR.S351913 |
work_keys_str_mv | AT ullahaman benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment AT alkurylinatariq benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment AT althobaitiyusufs benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment AT alitahir benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment AT shahfawadali benzimidazolederivativesasnewpotentialnlrp3inflammasomeinhibitorsthatprovideneuroprotectioninarodentmodelofneurodegenerationandmemoryimpairment |